[ Price : $8.95]
Two stakeholders give FDA recommendations on a draft guidance on assessing drug-drug interactions in therapeutic proteins.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for Regulations for In Vivo Radiopharmaceutical...[ Price : $8.95]
Federal Register notice: FDA has published a list of seven information collections that have been approved by OMB.[ Price : $8.95]
Pfizer says its investigational atopic dermatitis drug abrocitinib met its primary and key secondary endpoints in the Phase 3 JADE...[ Price : $8.95]
A U.S. Senate Appropriations Committee-released bill for fiscal year 2021 proposes $3.21 billion in discretionary funding for FDA,...[ Price : $8.95]
FDA gives de novo marketing authorization to the NightWare therapeutic platform to interrupt PTSD-associated nightmares.[ Price : $8.95]
FDA approves a Sebela Pharmaceuticals NDA for Sutab (sodium sulfate, magnesium sulfate, and potassium chloride) tablets, indicated...[ Price : $8.95]
FDA gives fast track designation to Surface Oncologys SRF 388 investigational liver cancer drug.